Evidence map›Paper›PMID 38139837›Full record

ArticlePharmaceuticals (Basel, Switzerland)2023

Chemotherapeutic Activity of Imidazolium-Supported Pd(II)

Aeshah A Awaji, Moustafa A Rizk, Raiedhah A Alsaiari, Norah F Alqahtani, Fatima A Al-Qadri, Ali S Alkorbi, Hani S Hafez, Reda F M Elshaarawy

Erratum issuedOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Aeshah A AwajiDepartment of Biology, Faculty of Science, University College in Taymaa, University of Tabuk, Tabuk 71491, Saudi Arabia.
Moustafa A RizkDepartment of Chemistry, Faculty of Science and Arts at Sharurah, Najran University, Sharurah 68342, Saudi Arabia.ORCID 0000-0002-4482-2992
Raiedhah A AlsaiariDepartment of Chemistry, Faculty of Science and Arts at Sharurah, Najran University, Sharurah 68342, Saudi Arabia.
Norah F AlqahtaniDepartment of Chemistry, College of Science, University of Jeddah, Jeddah 21589, Saudi Arabia.
Fatima A Al-QadriDepartment of Chemistry, Faculty of Science and Arts at Sharurah, Najran University, Sharurah 68342, Saudi Arabia.
Ali S AlkorbiDepartment of Chemistry, Faculty of Science and Arts at Sharurah, Najran University, Sharurah 68342, Saudi Arabia.
Hani S HafezZoology Department, Faculty of Science, Suez University, Suez 43533, Egypt.ORCID 0000-0002-8899-9941
Reda F M ElshaarawyDepartment of Chemistry, Faculty of Science, Suez University, Suez 43533, Egypt.ORCID 0000-0003-2100-8928
Najran University · SASuez University · EGUniversity of Jeddah · SAUniversity of Tabuk · SA

Funding

Najran University NU/IFC/2/SERC/-/7
6 · The paper itself

Abstract

Two bis-(imidazolium-vanillylidene)-(

Indexed as

apoptosiscytotoxicityFGFR2/FGF2HER2/neuimidazolium–vanillylidene ligandsPd(II) complexes-enacapsulated nanolipids

Identifiers

PMID38139837
PMCPMC10747766
OpenAlexW4389571024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.